Skip to main content
Equibles
TEM logo

TEM · Tempus AI, Inc. · Metrics

Track TEM — free

Use TEM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TEM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$64.34 -0.38 (-0.59%) At close · Oct 19
Russell 1000 member Rebalance outlook locked
Market Cap
$11.68B
Shares
180.43M
Volume · Oct 19 4.18M Avg daily vol (3M) 6.92M

TEM metrics

70 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$64.34
Market cap
$11.68B

Price action

20 metrics
Price change (1W)
-5.4%
Price change (30D)
-17.5%
Price change (3M)
+32.9%
Price change (6M)
+13.3%
Price change (YTD)
+9.0%
Price change (1Y)
-26.7%
Trailing year
Price change (5Y)
—
52-week high
$92.45
52-week low
$41.55
Change from 52-week high
-30.4%
Change from 52-week low
+54.8%
Annualized volatility
74.6%
Annualized volatility (3M)
95.4%
Beta
2.6
RSI (14D)
41.1
Price vs SMA 50
-5.5%
Price vs SMA 200
+13.3%
Avg volume (3M)
6.92M
Relative volume
0.6
Average dollar volume
$450.74M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
180.43M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
8.2×
reciprocal yield 12.3%
P / book
26.2
reciprocal yield 3.8%
FCF yield
-2.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-2.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
—
Operating margin
-19.8%
Trailing 12 months
Net margin
-17.8%
Gross profit (TTM)
—
Operating profit (TTM)
−$283.03M
Net income (TTM)
−$254.43M
Trailing 12 months
Diluted EPS (TTM)
$-1.44
FCF margin
-18.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$8,013.97
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1,582.96
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-1,433.93
Operating cash flow per diluted share (TTM)
$-1,342.25
Free cash flow per diluted share (TTM)
$-1,486.69
Capital expenditures per diluted share (TTM)
$144.44
R&D per diluted share (TTM)
$1,098.45
Stock compensation per diluted share (TTM)
$1,039.98
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+21.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.43B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+5.2%
Year over year · more shares
Revenue CAGR (3Y)
+58.3%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-57.2%
Return on assets
-10.8%
Debt / equity
—
Current ratio
3.3
EBITDA (TTM)
—
Free cash flow (TTM)
−$263.22M
Quick ratio
3.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$599.61M
Latest balance sheet
Cash & equivalents
$599.61M
Total assets
$2.37B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$237.43M
Capital expenditures (TTM)
$25.79M
R&D (TTM)
$196.31M
SG&A (TTM)
$834.84M
Stock compensation (TTM)
$186.15M
R&D / revenue
13.7%
Stock compensation / revenue
13.0%

Ownership (13F)

3 metrics
13F filers
503
13F filer change QoQ
+69
Institutional ownership
75.8%

Short interest

3 metrics
Short interest
13.9%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$84.54M
Insider-sentiment score
14 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1717115 CUSIP 88023B103 13F (30d) 63 filings 63 filers Visit website Investor relations